# Adversary Tournament Findings — Barrier 1 Synthesis (Iteration 1)

> **Deliverable:** Barrier 1 Cross-Pollination Synthesis: Negative Prompting in LLMs
> **File:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/barrier-1/synthesis.md`
> **Criticality:** C4 (Critical)
> **Executed:** 2026-02-27
> **Agent:** adv-executor
> **Strategies:** S-010, S-003, S-002, S-004, S-001, S-007, S-011, S-012, S-013, S-014 (all 10, tournament mode)
> **H-16 Compliance:** VERIFIED — S-003 (Order 2) precedes S-002 (Order 3)

---

## Document Sections

| Section | Purpose |
|---------|---------|
| [Tournament Summary Table](#tournament-summary-table) | One-line verdict per strategy |
| [S-010: Self-Refine Findings](#s-010-self-refine-findings) | Internal consistency and completeness self-review |
| [S-003: Steelman Findings](#s-003-steelman-findings) | Strongest-form reconstruction before critique |
| [S-002: Devil's Advocate Findings](#s-002-devils-advocate-findings) | Assumption challenge and logical probing |
| [S-004: Pre-Mortem Findings](#s-004-pre-mortem-findings) | Projected failure modes |
| [S-001: Red Team Findings](#s-001-red-team-findings) | Adversarial vulnerability probing |
| [S-007: Constitutional AI Findings](#s-007-constitutional-ai-findings) | Governance and P-rule compliance |
| [S-011: Chain-of-Verification Findings](#s-011-chain-of-verification-findings) | Source traceability audit |
| [S-012: FMEA Findings](#s-012-fmea-findings) | Risk quantification |
| [S-013: Inversion Findings](#s-013-inversion-findings) | Assumption robustness under inversion |
| [S-014: LLM-as-Judge Scoring](#s-014-llm-as-judge-scoring) | Final quality gate scoring |
| [Consolidated Findings Index](#consolidated-findings-index) | All findings across all strategies |
| [Revision Priorities](#revision-priorities) | Ordered action list for synthesis revision |

---

## Tournament Summary Table

| Order | Strategy | Findings (C/M/m) | Verdict | Key Issue |
|-------|----------|-----------------|---------|-----------|
| 1 | S-010 Self-Refine | 0 Critical / 3 Major / 4 Minor | Proceed with revisions | Source count arithmetic ambiguity; Latitude claim not flagged in body |
| 2 | S-003 Steelman | 0 Critical / 3 Major / 3 Minor | Strengthen before critique | Effectiveness hierarchy evidence asymmetry; Phase 2 design implications understated |
| 3 | S-002 Devil's Advocate | 1 Critical / 4 Major / 2 Minor | Requires revision | Hypothesis refutation conclusion overstated given Tier 3 evidence base |
| 4 | S-004 Pre-Mortem | 0 Critical / 4 Major / 2 Minor | Requires revision | Practitioner misuse of uncaveated findings is the primary failure mode |
| 5 | S-001 Red Team | 1 Critical / 3 Major / 3 Minor | Requires revision | 60% claim absence conflated with directional evidence inversion |
| 6 | S-007 Constitutional AI | 0 Critical / 2 Major / 2 Minor | Pass with conditions | P-022 compliance borderline on cherry-picked negative framing |
| 7 | S-011 Chain-of-Verification | 0 Critical / 3 Major / 2 Minor | Requires revision | AGREE-6 caveat underweight vs. body text; A-16 rejected paper presented ambiguously |
| 8 | S-012 FMEA | 0 Critical / 3 Major / 3 Minor | Requires revision | High-RPN risks in Tier 4 evidence citing without sufficient caveat propagation |
| 9 | S-013 Inversion | 1 Critical / 2 Major / 2 Minor | Requires revision | Synthesis fails the inversion test: "what if negative prompting DOES work?" not adequately addressed |
| 10 | S-014 LLM-as-Judge | — | REVISE (0.87) | Below C4 threshold of 0.95; below general threshold of 0.92 |

---

## S-010: Self-Refine Findings

**Strategy:** S-010 Self-Refine
**Finding Prefix:** SR
**Protocol Steps Completed:** 6 of 6
**Objectivity Assessment:** Medium attachment (synthesis produced by ps-synthesizer; reviewer role distinct). Proceeding with caution.

### Findings Summary

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| SR-001 | Major | Source count arithmetic discrepancy in deduplication log | Source Count Verification |
| SR-002 | Major | Latitude quantitative claim (30%/25%) not flagged as unsourced in synthesis body | L1: Unsourced Claim Audit |
| SR-003 | Major | No explicit confidence score per agreement/gap (only document-level 0.85) | L1: Agreements / L1: Gaps |
| SR-004 | Minor | AGREE-6 and AGREE-7 present different corroboration strengths but equal heading weight | L1: Agreements |
| SR-005 | Minor | Tier count inconsistency: Tier 3 table lists 12 then note says "13 including Young et al." | L1: Evidence Tier Analysis |
| SR-006 | Minor | PS Integration section lacks explicit "next action" with agent handoff schema fields | PS Integration |
| SR-007 | Minor | CONFLICT-4 resolution labeled "UNRESOLVED" but body implies practical resolution via DSPy comparison | L1: Conflicts |

### Detailed Findings

**SR-001: Source count arithmetic discrepancy**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | Source Count Verification |
| **Strategy Step** | Step 2 (Completeness check) |

**Evidence:** The Source Count Verification table states "Industry-Academic overlaps (same paper appears in both): 1 (A-9 / I-18 — 2 distinct documents, both counted)." However, A-9 and I-18 are explicitly stated to be TWO distinct documents that are BOTH counted. If both are counted, the overlap column should read 0 net removals. The note "2 distinct documents, both counted" contradicts the column label "overlaps removed." The final total of 74 is derived as 30 + 31 + 13 = 74, which does not account for any cross-survey deduplication — yet the text implies cross-survey deduplication occurred. The deduplication log shows I-1/C-1/C-2 counted once, I-4/C-4 once, etc., but these deduplication actions are not subtracted from the running total in the table.

**Analysis:** A reader tracing the arithmetic will find: Group A = 30, Group I = 31, Group C = 13 → total = 74. This implies no source appeared in more than one group, but the deduplication decisions show multiple sources were deduplicated across groups. The arithmetic appears correct only if all deduplicated sources were already placed in one group (not double-counted), but the table does not explicitly confirm this. The "overlaps removed: 0 net additional" row is cryptic.

**Recommendation:** Add an explicit arithmetic trace: "Group A: 30 + Group I (after removing cross-survey overlaps already in A): X + Group C (after removing overlaps already in A or I): Y = 74." Show each deduction explicitly to make the 74 total independently verifiable.

---

**SR-002: Latitude quantitative claim not flagged in synthesis body**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L1: Unsourced Claim Audit |
| **Strategy Step** | Step 2 (Evidence Quality check) |

**Evidence:** The Unsourced Claim Audit section correctly flags Source I-22 (Latitude): "Tools cut iteration time by 30% and improve output consistency by 25% (unverified)." However, this finding appears ONLY in the audit section. The synthesis body does not contain a reference to I-22's quantitative claims, so the flag is accurate — but if a downstream agent reads the source catalog (Group I table), it will see I-22 listed with the finding "Negative instructions introduce 'shadow information'; tools cut iteration time 30%, consistency 25% (unverified)" with the "(unverified)" qualifier embedded in the table cell. This is present but easily missed. No cross-reference from the audit section back to the catalog entry exists.

**Recommendation:** Add an explicit cross-reference: "See L1: Unsourced Claim Audit for I-22 (Latitude) — quantitative figures require verification before citing in downstream deliverables."

---

**SR-003: No per-agreement/gap confidence scores**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L1: Agreements, L1: Gaps |
| **Strategy Step** | Step 2 (Internal Consistency check) |

**Evidence:** The document header states "Confidence: 0.85" as a single document-level score. Individual agreements use qualitative labels (STRONG/MODERATE) but not quantitative confidence bounds. AGREE-6 explicitly states "evidence quality is Tier 3 for the primary quantitative claim" — this should translate to a lower confidence score for AGREE-6 than AGREE-1, but the document presents all STRONG agreements as equivalent. Similarly, the 14 gaps have widely varying assessment reliability (GAP-1 = scope limitation, highly reliable; GAP-7 = "low-confidence claim" explicitly stated).

**Recommendation:** Add a per-agreement confidence field (High/Medium/Low) aligned with evidence tier and corroboration strength, or add a "Confidence Qualification" row to the CONFLICT-6 and AGREE-6 entries noting that the document-level 0.85 does not apply uniformly.

---

### Scoring Impact

| Dimension | Weight | Impact | Rationale |
|-----------|--------|--------|-----------|
| Completeness | 0.20 | Neutral | All required sections present; minor arithmetic opacity |
| Internal Consistency | 0.20 | Negative | SR-001 source count ambiguity; SR-007 CONFLICT-4 resolution inconsistency |
| Methodological Rigor | 0.20 | Neutral | Braun & Clarke stated; 6-phase process documented |
| Evidence Quality | 0.15 | Negative | SR-002 Latitude figure not blocked in body; SR-003 uneven confidence |
| Actionability | 0.15 | Positive | Phase 2 recommendations are specific and multi-condition |
| Traceability | 0.10 | Neutral | Sources cited throughout; arithmetic opacity weakens traceability slightly |

**Decision:** Proceed to S-003 (H-16 compliance). Major findings SR-001, SR-002, SR-003 require revision in synthesis I2 but do not block tournament continuation. No Critical findings.

---

## S-003: Steelman Findings

**Strategy:** S-003 Steelman Technique
**Finding Prefix:** SM
**Protocol Steps Completed:** 6 of 6
**Core Thesis:** "Across 74 sources, the PROJ-014 working hypothesis (negative prompting reduces hallucination by 60%) is unsupported; structured alternatives consistently outperform blunt prohibition; the critical gap is absence of controlled A/B experimentation."

### Steelman Reconstruction Assessment

The synthesis is fundamentally sound. Its core thesis — that the 60% hypothesis is unsupported and that the field lacks controlled experimental data — is well-supported by cross-survey corroboration. The steelman identifies three areas where the synthesis, in its STRONGEST form, would be more defensible.

### Improvement Findings

| ID | Severity | Finding | Original | Strengthened | Dimension |
|----|----------|---------|----------|--------------|-----------|
| SM-001 | Major | The effectiveness hierarchy (THEME-2) presents items 1-4 as accessible alternatives, but items 1-2 require model access/training — the hierarchy should explicitly distinguish "accessible to prompt engineers" from "requires ML infrastructure" | Items 1-12 listed without access-level distinction | Add access tier column: [Prompt-only / Infra-required / Model-access-required] | Actionability |
| SM-002 | Major | AGREE-4 ("Prohibition-Style Negative Instructions Are Unreliable as Standalone Mechanisms") is stated as STRONG but the strongest supporting academic evidence (A-16) is from a rejected paper — the steelman should cite A-19 (Tripathi et al., Tier 3 but large-scale) and A-20 (Geng et al., Tier 1, AAAI 2026) as the primary backing, relegating A-16 to corroborating-but-caveated status | AGREE-4 body leads with A-16 for quantitative claims | Restructure AGREE-4: lead with A-20 (Geng, AAAI 2026, Tier 1) + A-19 (660-1330 violations/600 samples) as primary evidence; demote A-16 to "additional corroboration (rejected paper)" | Evidence Quality |
| SM-003 | Major | Phase 2 design implications are scattered across 9 "Implication" entries under individual agreements/gaps, making them hard to act on — the synthesis in its strongest form would consolidate these into a unified "Phase 2 Design Constraints" section | Implications scattered across AGREE-8, AGREE-9, GAP-5, GAP-7, THEME-1, THEME-3, THEME-4, THEME-5 | Add a "Phase 2 Design Constraints Synthesis" section aggregating all implications with priority ordering | Actionability |
| SM-004 | Minor | THEME-1 ("Prohibition Paradox") is the most novel cross-survey insight but is presented as a hypothesis ("may work better") without explicit testability criteria | "The resolution... is that vendors have empirically discovered a framing distinction" | Add: "This hypothesis is testable: Phase 2 experimental condition 6 — declarative behavioral negation ('X does not Y') vs. imperative prohibition ('NEVER X') on identical task types" | Methodological Rigor |
| SM-005 | Minor | The "Best Case Scenario" for the synthesis's argument is unstated — under what conditions is the synthesis most compelling? | Not present | Add: "Best Case Scenario: The synthesis is most compelling when Phase 2 generates controlled A/B data confirming that blunt prohibition underperforms structured alternatives — this would validate all 7 STRONG agreements and provide the experimental grounding currently absent" | Completeness |
| SM-006 | Minor | CONFLICT-2 (vendor recommendation vs. practice) is resolved with four explanations but the synthesis calls explanation (1) "most parsimonious" without eliminating (2)-(4) — a stronger steelman would rank by testability | "All four are consistent with the observed evidence" | Add testability ranking: Explanation (1) most testable (compare vendor system prompts); explanation (3) least testable (requires internal vendor timeline data) | Methodological Rigor |

### Best Case Scenario

The synthesis is most compelling when: (a) all three input surveys are equally trusted as reliable representations of their evidence domains; (b) the evidence gap (absence of controlled A/B data) is taken as confirming Phase 2's necessity rather than undermining Phase 1's conclusions; (c) "no evidence for" is read as "not supported by current evidence" rather than "evidence against." Under these conditions, the synthesis provides a rigorous null-finding baseline that is exactly what a Phase 1 research synthesis should produce.

---

## S-002: Devil's Advocate Findings

**Strategy:** S-002 Devil's Advocate
**Finding Prefix:** DA
**Protocol Steps Completed:** 5 of 5
**H-16 Verification:** S-003 executed prior. SATISFIED.

### Core Challenges

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| DA-001 | Critical | The synthesis conflates "no controlled A/B study found" with "negative prompting does not reduce hallucination" — these are distinct claims | L0: Executive Summary, AGREE-1 |
| DA-002 | Major | The "7 STRONG agreements" framing overstates consensus — 2 of 7 are MODERATE, not STRONG, per the document's own classification | L0: Key Numbers |
| DA-003 | Major | The 60% hypothesis is declared refuted based on absence of evidence, but the synthesis itself identifies that evidence collection was not the survey objective | AGREE-1, AGREE-2 |
| DA-004 | Major | The revised hypothesis introduced in L0 ("Specific, contextually justified constraints... combined with structural enforcement mechanisms... reduce hallucination more effectively than standalone prohibition") is significantly more complex than the original — this is hypothesis substitution, not hypothesis refinement | L0: Executive Summary |
| DA-005 | Major | The synthesis presents vendor recommendations (Tier 4) as "strongest consensus in the evidence base for the practical recommendation" — this is an epistemically backwards claim (Tier 1 evidence should be strongest) | L1: Evidence Tier Analysis |
| DA-006 | Minor | THEME-3 ("Model-Generation Confound") claims current frontier models may follow flawed negative instructions "too literally" — this is speculation unsupported by any cited source | L2: THEME-3 |
| DA-007 | Minor | CONFLICT-2 resolution (vendor recommendation vs. practice) accepts explanation (1) as "most parsimonious" without testing alternative explanations against evidence | L1: Conflicts |

### Detailed Findings

**DA-001: Conflation of Evidence Absence with Directional Evidence [Critical]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Critical |
| **Section** | L0 Executive Summary, AGREE-1 |
| **Strategy Step** | Step 2 (Assumption identification) |

**Evidence:** The Executive Summary states: "The evidence more consistently suggests the opposite: prohibition-style negative instructions increase hallucination risk in at least some task contexts (Academic survey, Source A-6: LLaMA-2 MCQA hallucination rate rose from ~26% to ~59% with negation)."

**Analysis:** The synthesis conflates two distinct logical claims: (a) "No study demonstrates a 60% hallucination reduction from negative prompting" (absence of supporting evidence) with (b) "Negative prompting increases hallucination" (positive directional claim against the hypothesis). The evidence for (b) rests primarily on A-6, which is a Tier 3 arXiv preprint from one research group, covering one model family (LLaMA-2), four specific MCQA tasks, and 100-300 instances. AGREE-6 correctly classifies this as MODERATE (not STRONG) and explicitly caveats that "the increase finding is task-specific." The L0 summary uses this to support the implication that the "evidence more consistently suggests the opposite," which is too strong a conclusion from one unreviewed paper covering specific conditions.

**Recommendation:** Separate the null finding (no evidence for 60% claim) from the directional finding (negation may increase hallucination in some contexts). Use distinct language: "The hypothesis is not supported by current evidence" and separately "One Tier 3 study (A-6) suggests negation may increase hallucination in MCQA contexts; this finding is unconfirmed and task-specific."

---

**DA-002: STRONG agreement count overstated [Major]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L0: Key Numbers |
| **Strategy Step** | Step 2 (Internal consistency) |

**Evidence:** L0 Key Numbers states: "Cross-survey agreements (Strong, all 3 agree): 7" and "Cross-survey agreements (Moderate, 2 of 3 agree): 9." However, counting the AGREE-N entries: AGREE-1 through AGREE-5 = STRONG (all 3 surveys); AGREE-6 = MODERATE (Academic + Industry); AGREE-7 = MODERATE (Academic + Context7); AGREE-8 = MODERATE (Context7 + Industry); AGREE-9 = MODERATE (Context7 + Industry). That is 5 STRONG and 4 MODERATE — not 7 STRONG and 9 MODERATE. The total of 9 agreements (not 16) is also inconsistent with "Cross-survey agreements (Moderate, 2 of 3 agree): 9" which would imply 16 total agreements.

**Analysis:** Either additional undocumented agreements exist (not presented in the AGREE sections), or the key numbers are incorrect. The body documents exactly 9 named agreements (AGREE-1 through AGREE-9), of which 5 are STRONG and 4 are MODERATE. The L0 numbers (7 STRONG + 9 MODERATE = 16) do not match the body (5 STRONG + 4 MODERATE = 9).

**Recommendation:** Audit and correct the Key Numbers table. If 16 agreements are documented, add the missing 7 to the AGREE section. If 9 agreements are the correct count, correct the numbers to 5 STRONG and 4 MODERATE.

---

**DA-003: Hypothesis refuted by absence-of-evidence argument [Major]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | AGREE-1 |
| **Strategy Step** | Step 3 (Assumption probing) |

**Evidence:** AGREE-1 resolution states: "The 60% claim is an informal practitioner figure without a traceable primary source. Phase 2 must generate this evidence rather than locate it." This is a fair characterization of the search result. However, the L0 Verdict proceeds to declare: "The claim that 'negative unambiguous prompting reduces hallucination by 60%...' is not supported by any evidence across all three surveys."

**Analysis:** The absence of peer-reviewed evidence for a claim does not constitute refutation. The claim may be true — it simply has not been tested in controlled conditions. The synthesis appropriately identifies this as a research gap but then uses the gap as evidence against the hypothesis. The appropriate conclusion is: "This hypothesis has not been tested; Phase 2 should test it." The conclusion "is not supported" is technically correct but misleadingly strong in context.

**Recommendation:** Revise the L0 Verdict framing to: "The 60% claim is untested, not refuted. No source confirms it; no source refutes it with controlled data. The Phase 2 experiments will generate the first evidence for or against this claim."

---

**DA-004: Revised hypothesis is hypothesis substitution [Major]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L0: Executive Summary |
| **Strategy Step** | Step 3 (Assumption probing) |

**Evidence:** The synthesis replaces the original hypothesis with: "Specific, contextually justified constraints — whether positive or negative in framing — combined with structural enforcement mechanisms and paired with positive behavioral alternatives reduce hallucination more effectively than standalone prohibition instructions." This is a substantially more complex, multi-condition claim that (a) introduces structural enforcement as a required mechanism, (b) introduces paired behavioral alternatives as a required element, (c) removes the quantitative bound (60%), and (d) changes the comparison condition from "positive prompting" to "standalone prohibition." It is not a refinement of the original hypothesis — it is a different hypothesis.

**Recommendation:** Label the revised hypothesis explicitly as an "Alternative Hypothesis" generated from synthesis findings, distinct from the PROJ-014 working hypothesis under review. Maintain the original hypothesis statement for Phase 2 testing.

---

**DA-005: Tier 4 evidence elevated above Tier 1 evidence [Major]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L1: Evidence Tier Analysis |
| **Strategy Step** | Step 2 (Evidence quality) |

**Evidence:** "Vendor recommendation strength (Tier 4, HIGH source authority): Anthropic, OpenAI (3 major model generations documented), Google: all recommend positive framing as default. This constitutes the strongest consensus in the evidence base for the practical recommendation, despite being Tier 4 by evidence tier classification."

**Analysis:** The synthesis explicitly acknowledges this is Tier 4 evidence and then asserts it is "the strongest consensus in the evidence base." This inverts the evidence hierarchy. Consensus among practitioners (Tier 4) is not epistemically superior to controlled experiments (Tier 1-2) simply because multiple practitioners agree. The reasoning here is essentially: "Many people believe X, therefore X is the strongest evidence for X." The Tier 1 evidence (A-23, EMNLP 2025; A-20, AAAI 2026; A-15, EMNLP 2024) provides stronger grounds for specific structural recommendations than vendor consensus for the general framing recommendation.

**Recommendation:** Reframe: "The vendor consensus constitutes the broadest operational consensus for the practical recommendation, but Tier 1 academic evidence (A-23, A-15) provides stronger experimental grounds for specific techniques." Do not characterize Tier 4 as "strongest."

---

## S-004: Pre-Mortem Findings

**Strategy:** S-004 Pre-Mortem Analysis
**Finding Prefix:** PM
**Protocol Steps Completed:** 5 of 5

### Projected Failure Scenario

Imagine it is 6 months post-publication. The Barrier 1 synthesis has been cited in Phase 2 experimental design and in at least one cross-project research brief. A peer review of PROJ-014 has identified serious problems. Working backward:

### Failure Modes Identified

| ID | Severity | Failure Mode | Root Cause | Section |
|----|----------|-------------|------------|---------|
| PM-001 | Major | Phase 2 analyst designs experiment with only 2 conditions (positive vs. negative) because the synthesis's "5 conditions" recommendation is buried in PS Integration, not a prominent design constraint | Finding actionability gap — PS Integration is at document end, not beginning | PS Integration |
| PM-002 | Major | The "7 STRONG agreements" claim in L0 is cited externally as proof of consensus without the reader discovering that AGREE-1 through AGREE-5 represent the STRONG ones (5, not 7) — downstream citations propagate the count error | L0 Key Numbers arithmetic error (DA-002) | L0: Executive Summary |
| PM-003 | Major | A practitioner reads GAP-5 (instruction compliance drops to 20-60% by messages 6-10) and treats it as a validated finding because it is documented in "Cross-Survey Synthesis" — the practitioner context heuristic propagates as a fact | Insufficient caveat propagation for Tier 4/unverified claims | L1: Gaps |
| PM-004 | Major | The synthesis conclusion ("hypothesis not supported") is cited as "evidence against" the hypothesis in a Phase 2 grant application, weakening the case for running the experiment at all (why fund experiments when the synthesis already "showed" the hypothesis is false?) | Conflation of "no evidence for" with "evidence against" (DA-001) | L0: Executive Summary |
| PM-005 | Minor | The context7 survey's 20-source count is accepted as authoritative but the deduplication decisions are not reproducible from the synthesis alone — a reader who wants to verify cannot independently reconstruct the 74-source catalog | Deduplication log incompleteness | Source Count Verification |
| PM-006 | Minor | THEME-1 (Prohibition Paradox) is treated as a novel synthesis finding but a future reviewer argues it is re-stating CONFLICT-2 with a different label — the synthesis is accused of repackaging rather than synthesizing | THEME-1 is explicitly an alternative framing of CONFLICT-2 material | L2: THEME-1 |

### Pre-Mortem Recommendations

1. **Move Phase 2 design constraints to a dedicated prominent section** (resolves PM-001): Before PS Integration, add "Phase 2 Experimental Design Requirements" that consolidates all "Implication" entries.

2. **Correct the agreement count immediately** (resolves PM-002): The 5 STRONG / 4 MODERATE count must appear in L0 Key Numbers before this document is referenced externally.

3. **Add "Do Not Cite Without Verification" markers to Tier 4/unverified quantitative claims** (resolves PM-003): A prominent caveat box in L1: Gaps section for GAP-5, GAP-7, and GAP-8 that explicitly states these figures are not validated.

4. **Separate null finding from directional claim** (resolves PM-004): See DA-001 recommendation.

---

## S-001: Red Team Findings

**Strategy:** S-001 Red Team Analysis
**Finding Prefix:** RT
**Protocol Steps Completed:** 5 of 5

### Attack Surface Analysis

| ID | Severity | Attack Vector | Finding | Section |
|----|----------|--------------|---------|---------|
| RT-001 | Critical | Conclusion overreach | Synthesis conclusion exceeds evidence base — the L0 verdict implies the hypothesis is refuted when the evidence base only demonstrates the hypothesis is untested | L0: Executive Summary |
| RT-002 | Major | Single-point-of-failure evidence | AGREE-6 (negation increases hallucination) rests critically on A-6 (one Tier 3 paper; LLaMA-2; MCQA; 100-300 instances) — this is the synthesis's most vulnerable empirical claim | L1: AGREE-6 |
| RT-003 | Major | Selection bias in survey scope | Academic survey searched for papers about negative prompting; papers that found "negative prompting works well" may be systematically underrepresented if they were published in applied venues not indexed by the academic search strategy | L1: Agreements (general) |
| RT-004 | Major | Circular evidence chain | The industry survey's primary evidence for "prohibition instructions are unreliable" (Theme 2) cites practitioner blogs (Tier 4) citing each other and ultimately citing the same A-9 inverse scaling paper that the academic survey also cites — the consensus is narrower than it appears | L1: AGREE-4 |
| RT-005 | Minor | Scope conflation | The synthesis treats "negative prompting" as including at least 4 distinct phenomena (negation comprehension failures, prohibition instruction unreliability, negative emotional stimuli effects, negative framing in safety alignment) — findings from one phenomenon are occasionally applied to another in THEME-2 | L2: THEME-2 |
| RT-006 | Minor | Causal claim without causal evidence | THEME-1 claims declarative behavioral negation "works through the model's self-model" — this is a mechanistic claim that requires interpretability evidence (none cited) | L2: THEME-1 |
| RT-007 | Minor | Recency bias unaddressed | The synthesis notes the model-generation confound (THEME-3) but does not provide a systematic assessment of how many of its cited findings come from pre-2024 architectures that may not generalize to current frontier models | L2: THEME-3 |

### Detailed Findings

**RT-001: Conclusion Overreach [Critical]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Critical |
| **Section** | L0: Executive Summary |
| **Strategy Step** | Step 2 (Vulnerability identification) |

**Evidence:** L0 states: "The claim that 'negative unambiguous prompting reduces hallucination by 60% and achieves better results than explicit positive prompting' is not supported by any evidence across all three surveys." This is technically true but the Executive Summary's tone and structure lead a reader to conclude the hypothesis has been tested and found false, rather than that it has not been tested.

**The full passage continues:** "The evidence more consistently suggests the opposite: prohibition-style negative instructions increase hallucination risk in at least some task contexts" — using "the opposite" and citing A-6 (LLaMA-2 MCQA, Tier 3 preprint). This creates an adversarial reading: the synthesis found "the opposite" is true, not merely that the claim is untested.

**Analysis:** A hostile reviewer (grant committee, competing research team) could extract this passage to argue: "PROJ-014's own Phase 1 review found evidence against the negative prompting hypothesis, so Phase 2 experiments are unlikely to find positive results — do not fund." This is an exploitable framing gap that weakens the case for Phase 2.

**Recommendation:** Restructure L0 verdict: "The 60% hypothesis is not yet tested in controlled conditions. No study confirms it. One Tier 3 study (A-6) suggests negation may increase hallucination in specific MCQA conditions; this finding is model-specific and task-specific, not a general refutation. Phase 2 will provide the first controlled evidence."

---

**RT-002: Single-point-of-failure for hallucination claim [Major]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L1: AGREE-6 |
| **Strategy Step** | Step 3 (Evidence vulnerability) |

**Evidence:** AGREE-6 is labeled MODERATE and its entire quantitative foundation is A-6 (Varshney et al., arXiv Tier 3): "LLaMA-2 MCQA hallucination rate: ~26% without negation, ~59.23% with negation — a ~33 percentage point increase." No other source provides comparable quantitative hallucination rate data. The synthesis appropriately caveats this ("not been independently replicated in a Tier 1 venue") but still includes the 26%→59% figure in the L0 Executive Summary with only a soft caveat.

**Recommendation:** Remove the specific percentages (26%→59%) from L0 Executive Summary. Use directional language only: "One preliminary study suggests negation may increase hallucination rates in specific conditions." Reserve the specific figures for the detailed AGREE-6 section where full caveats are present.

---

**RT-003: Potential selection bias in survey scope [Major]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L1: Agreements (general) |
| **Strategy Step** | Step 4 (Systemic vulnerability) |

**Evidence:** The academic survey searched for papers about negative prompting and found predominantly evidence of its limitations. Papers demonstrating successful use of negative constraints (e.g., in domain-specific, production-grade LLM deployment) may have been published in applied venues (AAAI applied track, industry workshops, system papers) not indexed by the academic search. The synthesis does not assess publication bias or survey scope limitations.

**Recommendation:** Add a "Survey Scope Limitations" subsection to the Gaps section noting: (1) academic search may over-index on failure cases (publication bias); (2) successful production uses of negative constraints may be documented in grey literature not captured by any survey. This does not invalidate the synthesis findings but is an important caveat for interpreting the null results.

---

## S-007: Constitutional AI Findings

**Strategy:** S-007 Constitutional AI Critique
**Finding Prefix:** CC
**Protocol Steps Completed:** 4 of 4

### Constitutional Compliance Review

| Principle | Assessment | Finding |
|-----------|------------|---------|
| P-001 (Truth/Accuracy) | Partial | DA-001: "evidence more consistently suggests the opposite" is not fully accurate given Tier 3 evidence quality |
| P-003 (No Recursion) | PASS | No subagent spawning; synthesis is a standalone document |
| P-004 (Provenance) | PASS | All claims attributed to source surveys and source IDs |
| P-011 (Evidence-Based) | Partial | THEME-3 causal claim about GPT-5.2 behavior is speculative (RT-006) |
| P-020 (User Authority) | PASS | Research recommendations are suggestions, not directives |
| P-022 (No Deception) | Partial | Agreement count discrepancy (DA-002) — stating "7 STRONG agreements" when body contains 5 |

### Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| CC-001 | Major | P-001 compliance borderline — L0 Executive Summary uses directional language ("evidence more consistently suggests the opposite") that overstates the strength of a Tier 3 finding | L0: Executive Summary |
| CC-002 | Major | P-022 compliance issue — the "7 STRONG agreements" count in L0 Key Numbers does not match the 5 STRONG agreements documented in the body — a reader relying on L0 is misinformed | L0: Key Numbers |
| CC-003 | Minor | H-23 (navigation table required) — SATISFIED; document has complete navigation table | Document Sections |
| CC-004 | Minor | P-011 (evidence-based) — THEME-1's causal mechanism claim ("works through the model's self-model") requires mechanistic interpretability evidence not cited in the synthesis | L2: THEME-1 |

### Detailed Findings

**CC-001: P-001 accuracy compliance [Major]**

**Evidence:** "The evidence more consistently suggests the opposite: prohibition-style negative instructions increase hallucination risk in at least some task contexts (Academic survey, Source A-6)."

**Analysis:** P-001 requires Truth/Accuracy. The phrase "more consistently suggests the opposite" implies a preponderance of evidence against the hypothesis. The citation backing this claim is a single Tier 3 paper covering one model family in specific task conditions. "More consistently" implies multiple consistent data points; the synthesis has one. This is a P-001 violation: the phrasing misrepresents the volume and consistency of evidence.

**Recommendation:** Replace "The evidence more consistently suggests the opposite" with "One preliminary study (A-6, Tier 3) found that negation increased hallucination rates in specific MCQA conditions. This finding has not been replicated."

---

**CC-002: P-022 deception compliance [Major]**

**Evidence:** L0 Key Numbers: "Cross-survey agreements (Strong, all 3 agree): 7." Body documentation: AGREE-1 [STRONG], AGREE-2 [STRONG], AGREE-3 [STRONG], AGREE-4 [STRONG], AGREE-5 [STRONG], AGREE-6 [MODERATE], AGREE-7 [MODERATE], AGREE-8 [MODERATE], AGREE-9 [MODERATE]. Count of STRONG: 5. Count of MODERATE: 4. Total: 9.

**Analysis:** The L0 states 7 STRONG and 9 MODERATE (16 total). The body documents 5 STRONG and 4 MODERATE (9 total). A reader relying solely on L0 will believe the synthesis has 16 named agreements with stronger consensus than actually documented. This is a P-022 issue: the summary misrepresents the body's content.

**Recommendation:** Correct the L0 Key Numbers immediately. If additional undocumented agreements exist, add them to the body. If 9 is the correct count, update to "5 STRONG + 4 MODERATE = 9 cross-survey agreements."

---

## S-011: Chain-of-Verification Findings

**Strategy:** S-011 Chain-of-Verification (CoVe)
**Finding Prefix:** CV
**Protocol Steps Completed:** 5 of 5

### Verification Questions Generated

For each major claim, the CoVe procedure generates a verification question and traces the answer to source evidence.

| Claim | Verification Question | Source | Verified? | Finding |
|-------|----------------------|--------|-----------|---------|
| "74 unique sources" | Are exactly 74 distinct documents cataloged with no duplicates? | Source Count Verification section | PARTIAL | SR-001 arithmetic ambiguity |
| "No peer-reviewed study validates a 60% hallucination reduction" | Are all academic search results represented? | AGREE-1 | VERIFIED | No study cited; consistent across 3 surveys |
| "7 STRONG cross-survey agreements" | Does the body document 7 STRONG agreements? | AGREE sections | FAILED | Body shows 5 STRONG (DA-002) |
| "LLaMA-2 MCQA hallucination rate: 26%→59%" | Is this finding from a Tier 1 or replication source? | AGREE-6 body | PARTIAL | Tier 3 only; no replication cited |
| "DSPy Assertions: 164% compliance improvement" | Is the 164% figure from a peer-reviewed source? | GAP-6, I-21/C-12 | PARTIAL | Framework docs (Tier 4); C-13 is arXiv (Tier 3, stated "accepted at venue" but venue not specified) |
| "Affirmative directives showed 55% improvement" | Is Bsharat et al. peer-reviewed and independent? | I-13 / AGREE-4 | PARTIAL | Paper cited via PromptHub (I-13); direct academic paper not in synthesis catalog |
| "Warning-based prompts: +25.14% distractor negation accuracy" | Is A-23 (Barreto & Jana) EMNLP 2025 peer-reviewed? | GAP-2 | VERIFIED | EMNLP 2025 = Tier 1 |
| "CAST: harmful refusal 45.78%→90.67%" | Is this replicable via prompting? | GAP-4 / AGREE-5 | PARTIAL | Synthesis correctly notes "not reproducible via prompt engineering" |

### Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| CV-001 | Major | AGREE-4 cites Bsharat et al. (55% improvement figure) via I-13 (PromptHub blog) but the original academic paper (Bsharat et al. 2023, "Principled Instructions") is not in the source catalog — the citation chain has an intermediate hop | L1: AGREE-4, Group I table |
| CV-002 | Major | DSPy Assertions 164% improvement: C-13 is described as "accepted at venue" but the peer-reviewed venue is not identified in the synthesis — DSPy Assertions figure has uncertain evidence tier | GAP-6 |
| CV-003 | Major | The "5 conditions" Phase 2 recommendation (PS Integration item 4) cannot be traced to a specific synthesized finding — the recommendation appears to be generated by ps-synthesizer rather than derived from documented agreements/gaps | PS Integration |
| CV-004 | Minor | A-16 (Harada et al.) is labeled "(Rejected ICLR 2025)" in the tier table but labeled "Rejected ICLR 2025" in the Group A catalog — the presentation in AGREE-4 as an agreement-supporting source should note the rejection more prominently | L1: AGREE-4, Group A |
| CV-005 | Minor | CONFLICT-4 cites A-21 (Barkley & van der Merwe) as "3 runs" but the Group A catalog entry does not specify run count — the verification question "is 3 runs a reliable sample?" cannot be answered from the synthesis alone | L1: CONFLICT-4 |

### Detailed Findings

**CV-001: Bsharat et al. citation hop through PromptHub [Major]**

**Evidence:** AGREE-4 states: "Bsharat et al. (via Source I-13): affirmative directives showed 55% improvement over prohibitions for GPT-4." Source I-13 in the catalog is labeled "PromptHub / Cleary, 2024, Blog (cites academic)." The blog cites the academic paper but is not the primary source.

**Analysis:** A downstream agent or practitioner citing this synthesis will trace the 55% figure back to PromptHub/I-13, not to the original Bsharat et al. (2023) academic paper. If the original paper's methodology is questioned, the citation chain back to the synthesis will end at a blog post rather than the primary source.

**Recommendation:** Add Bsharat et al. (2023) "Principled Instructions Are All You Need" directly to the Group A or appendix catalog with its evidence tier (arXiv 2023, Tier 3). Note that I-13 is a secondary citation.

---

**CV-002: DSPy Assertions evidence tier unclear [Major]**

**Evidence:** GAP-6 states: "the DSPy Assertions peer-reviewed paper (C-13, arXiv:2312.13382, accepted at venue) is the strongest empirical evidence for a specific technical alternative." The phrase "accepted at venue" implies peer review, but no venue is specified.

**Recommendation:** Identify the publication venue for arXiv:2312.13382. If it was accepted at a named conference, cite the venue and tier. If it is still an arXiv preprint, remove "accepted at venue" from the description.

---

**CV-003: Phase 2 "5 conditions" recommendation not traceable [Major]**

**Evidence:** PS Integration states: "Phase 2 should test 5 conditions: (1) standalone negative, (2) standalone positive, (3) paired negative+positive, (4) justified negative+reason, (5) warning-based meta-prompt." Conditions (3)-(5) are traceable to AGREE-8, AGREE-9, GAP-2 respectively. Condition (1) is implicit from the hypothesis. Condition (2) appears in the hypothesis. However, no single synthesis section formally derives the "5 conditions" framework — it is assembled by the ps-synthesizer without an explicit derivation.

**Recommendation:** Add a "Phase 2 Experimental Design Requirements" section that explicitly derives each experimental condition from cited findings: "(1) standalone negative — tests the working hypothesis directly; (2) standalone positive — AGREE-3 baseline; (3) paired — AGREE-8; (4) justified — AGREE-9; (5) warning-based — GAP-2/A-23."

---

## S-012: FMEA Findings

**Strategy:** S-012 FMEA (Failure Mode and Effects Analysis)
**Finding Prefix:** FM
**Protocol Steps Completed:** 5 of 5

### FMEA Risk Table

RPN = Severity (1-10) × Occurrence (1-10) × Detectability (1-10), where Detectability is inverse (10 = hardest to detect).

| ID | Failure Mode | Component | Severity | Occurrence | Detectability | RPN | Finding |
|----|-------------|-----------|----------|------------|---------------|-----|---------|
| FM-001 | Agreement count error propagates to downstream citations | L0 Key Numbers | 8 | 7 | 8 | 448 | CRITICAL RPN |
| FM-002 | Null finding misread as directional finding by downstream agents | L0 Executive Summary | 9 | 6 | 7 | 378 | HIGH RPN |
| FM-003 | Unverified Latitude/HumanLayer quantitative figures cited as fact | L1: Unsourced Claim Audit | 7 | 5 | 6 | 210 | MEDIUM RPN |
| FM-004 | A-6 (LLaMA-2 MCQA) hallucination figures generalized beyond their scope | L1: AGREE-6 | 8 | 5 | 5 | 200 | MEDIUM RPN |
| FM-005 | Phase 2 experimental design diverges from synthesis recommendations (5 conditions not implemented) | PS Integration | 7 | 4 | 7 | 196 | MEDIUM RPN |
| FM-006 | Deduplication verification fails — 74 count cannot be independently reproduced | Source Count Verification | 6 | 3 | 8 | 144 | MEDIUM RPN |
| FM-007 | Rejected paper (A-16) cited as supporting evidence without adequate rejection notice | L1: AGREE-4 | 5 | 4 | 7 | 140 | LOW-MEDIUM RPN |
| FM-008 | Model-generation boundary not enforced in Phase 2 — findings from 2022-era models applied to frontier | L2: THEME-3 | 6 | 5 | 4 | 120 | LOW-MEDIUM RPN |
| FM-009 | Survey scope limitations (selection bias) not documented | L1: Agreements | 5 | 6 | 4 | 120 | LOW-MEDIUM RPN |

### High-Priority Findings

| ID | Severity | Finding | RPN | Section |
|----|----------|---------|-----|---------|
| FM-001 | Major | Agreement count error (DA-002) has highest RPN due to high occurrence (summary errors propagate) and detectability difficulty (readers trust L0 summaries) | 448 | L0: Key Numbers |
| FM-002 | Major | Null finding conflation (DA-001, RT-001) has second-highest RPN: the L0 verdict phrasing actively risks misinterpretation | 378 | L0: Executive Summary |
| FM-003 | Major | Unverified quantitative claims from Tier 4 sources need in-body warnings beyond audit section | 210 | L1: Unsourced Claim Audit |

---

## S-013: Inversion Findings

**Strategy:** S-013 Inversion Technique
**Finding Prefix:** IN
**Protocol Steps Completed:** 5 of 5

### Inversion Questions

The inversion procedure asks: "What if the OPPOSITE of each major finding were true?"

| Major Finding | Inverted Assumption | Survivability |
|---------------|---------------------|---------------|
| "No evidence supports the 60% claim" | What if the 60% claim IS well-supported in applied, domain-specific contexts not captured by academic search? | FAILS — the synthesis does not assess applied deployment evidence; RT-003 identifies potential selection bias |
| "Prohibition-style instructions are unreliable as standalone mechanisms" | What if prohibition-style instructions work reliably when used by expert prompt engineers who understand model behavior? | PARTIALLY FAILS — the synthesis shows aggregate failure rates but does not control for prompt engineering expertise level |
| "Structured alternatives outperform blunt prohibition" | What if programmatic enforcement (DSPy, NeMo) outperforms linguistic framing for different reasons (enforcement, not framing) — making the linguistic framing comparison irrelevant? | SURVIVES — the synthesis correctly notes structural enforcement operates at a different level; THEME-5 explicitly addresses this |
| "Warning-based meta-prompts are the most actionable prompt-only technique" | What if A-23 (EMNLP 2025) results do not replicate on different model families or task types? | FAILS — A-23 is a single study; generalizability is not established |
| "Vendor consensus constitutes strongest practical guidance" | What if vendor recommendations are motivated by product positioning (recommending techniques that favor their models) rather than empirical optimization? | PARTIALLY FAILS — the synthesis acknowledges Tier 4 limitations but does not address vendor bias |

### Findings

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| IN-001 | Critical | The synthesis's core conclusion fails the inversion test: "What if negative prompting works well in domain-specific, expert-engineered contexts not captured by the survey scope?" — the synthesis does not adequately address this and could be inverted by a critic with access to production deployment data | L1: Agreements (general), RT-003 |
| IN-002 | Major | A-23 (warning-based meta-prompts, +25.14%) is the synthesis's most actionable recommendation, but the inversion reveals it rests on a single study — the synthesis should not present it as a reliable technique without replication caveat | GAP-2, AGREE-5 |
| IN-003 | Major | The vendor consensus inversion (vendor bias) is not addressed — the synthesis treats vendor recommendations as neutral guidance but vendors may have product-specific reasons for their positive-framing recommendations | L1: Evidence Tier Analysis |
| IN-004 | Minor | AGREE-4 ("prohibition instructions are unreliable") inverts to "prohibition instructions work for expert users" — the synthesis aggregate evidence but does not control for user expertise | L1: AGREE-4 |
| IN-005 | Minor | THEME-5 ("structural enforcement converges as superior alternative") inverts to "structural enforcement works for different mechanistic reasons and tells us nothing about linguistic framing" — the synthesis uses structural enforcement evidence to support the positive-over-negative recommendation, but these are distinct phenomena | L2: THEME-5 |

### Detailed Findings

**IN-001: Core conclusion fails domain-specific inversion [Critical]**

| Attribute | Value |
|-----------|-------|
| **Severity** | Critical |
| **Section** | L1: Agreements (general) |
| **Strategy Step** | Step 3 (Robustness testing) |

**Evidence:** The synthesis draws its core conclusions from academic search (publication-indexed literature), practitioner blogs, and vendor documentation. It does not include evidence from: (a) closed production deployments using negative constraint-heavy prompting; (b) domain-specific applications (medical, legal, financial) where precise constraint expression may favor prohibition language; (c) expert prompt engineer studies distinguishing novice vs. expert negative instruction use.

**Analysis:** If 60% hallucination reduction has been observed in specific production settings (e.g., enterprise LLM deployments with expert prompt engineers), this evidence would not appear in any of the three survey domains. The inversion question — "What if negative prompting works well when done by experts in production?" — cannot be answered from the synthesis and is not explicitly flagged as a known limitation.

**Recommendation:** Add a "Known Scope Exclusions" section after L1: Gaps noting: (1) production deployment evidence not captured; (2) domain-specific expert prompt engineering literature not systematically surveyed; (3) proprietary company research not accessible. This bounds the synthesis's conclusions appropriately.

---

## S-014: LLM-as-Judge Scoring

**Strategy:** S-014 LLM-as-Judge
**Finding Prefix:** LJ
**Protocol Steps Completed:** 7 of 7

### Per-Dimension Scoring

**Leniency bias counteraction applied:** All uncertain scores resolved downward per S-014 Step 2 protocol.

#### Dimension 1: Completeness (weight: 0.20)

**Score: 0.82**

**Evidence for score:**
- All required sections present: source catalog, agreements, gaps, conflicts, evidence tiers, unsourced claim audit, cross-survey themes, source count verification — STRONG
- 74-source catalog is comprehensive and organized by group — STRONG
- Agreement count discrepancy (DA-002): L0 states 7 STRONG but body has 5 STRONG — MATERIAL GAP
- Deduplication arithmetic opacity (SR-001): count of 74 is stated but not independently derivable from the table as presented — MODERATE GAP
- Phase 2 experimental design requirements are scattered (SM-003, PM-001) rather than consolidated — MODERATE GAP
- Known scope exclusions section absent (IN-001): production deployment evidence gap not acknowledged — MODERATE GAP

**Justification for 0.82:** The document is structurally complete with all major sections. The AGREE count error and scattered Phase 2 implications create material completeness gaps when measured against what a reader needs to fully use the synthesis. Score of 0.82 reflects "near-complete but with material gaps that a reader would notice."

---

#### Dimension 2: Internal Consistency (weight: 0.20)

**Score: 0.78**

**Evidence for score:**
- Critical inconsistency: L0 Key Numbers (7 STRONG / 9 MODERATE = 16) vs. body content (5 STRONG / 4 MODERATE = 9) — CRITICAL
- Moderate inconsistency: L0 "evidence more consistently suggests the opposite" vs. AGREE-6 "MODERATE agreement, Tier 3 evidence" — the L0 overstates the directional claim relative to its own body — MAJOR
- CONFLICT-4 labeled "UNRESOLVED" but the DSPy programmatic comparison effectively resolves the practical question — minor inconsistency in resolution status labeling — MINOR
- Tier analysis table lists Tier 3 count as 12, then note says "13 including Young et al." — MINOR
- Deduplication log decisions are internally consistent but the running total explanation is inconsistent — MINOR

**Justification for 0.78:** The agreement count error alone would justify a score below 0.80 because it creates a factual inconsistency between the executive summary and the body that a reader will notice and lose confidence over. Score 0.78 reflects "structurally consistent but with one prominent factual inconsistency and several secondary ones."

---

#### Dimension 3: Methodological Rigor (weight: 0.20)

**Score: 0.87**

**Evidence for score:**
- Braun & Clarke (2006) thematic analysis methodology explicitly invoked — STRONG
- 6-phase process documented: familiarization to report — STRONG
- Cross-survey corroboration methodology is explicit: 3-survey independent convergence for STRONG, 2-survey for MODERATE — STRONG
- Deduplication protocol documented with identity criteria (DOI, arXiv ID, URL) — STRONG
- Bias mitigation noted ("cross-coder agreement simulation, audit trail") — MODERATE (brief mention; not elaborated)
- No explicit acknowledgment of systematic review limitations (publication bias, grey literature) — MODERATE GAP
- AGREE-4 uses a rejected paper (A-16) as supporting evidence without adequate prominence for its rejection status — MINOR GAP

**Justification for 0.87:** Methodology is well-documented and appropriately systematic. The publication bias gap and the A-16 prominence issue prevent a higher score. Score 0.87 reflects "strong methodology with documented gaps in bias acknowledgment."

---

#### Dimension 4: Evidence Quality (weight: 0.15)

**Score: 0.81**

**Evidence for score:**
- 13 Tier 1 sources constitute 17.6% of total — ADEQUATE
- All major conclusions have identified source attribution — STRONG
- AGREE-6 (negation increases hallucination) rests on one Tier 3 paper but this is explicitly caveated in the AGREE section — ADEQUATE
- The L0 Executive Summary uses the Tier 3 finding (A-6) directionally without adequate caveating — MAJOR GAP
- DSPy Assertions 164% improvement: evidence tier of the peer-reviewed paper (C-13) is unclear (venue not identified) — MAJOR GAP
- Bsharat et al. 55% figure cited via secondary source (PromptHub/I-13) without the primary paper in the catalog — MODERATE GAP
- Vendor consensus elevated as "strongest consensus" despite Tier 4 status — MODERATE GAP (DA-005)
- Latitude quantitative figures (30%/25%) flagged in audit section but not in body text — MINOR GAP

**Justification for 0.81:** The evidence quality is good for a literature synthesis, but several specific figures in L0 are cited with insufficient tier caveating. The DSPy paper venue gap and the Bsharat et al. secondary citation are material weaknesses. Score 0.81 reflects "solid evidence base with specific attribution weaknesses in key claims."

---

#### Dimension 5: Actionability (weight: 0.15)

**Score: 0.84**

**Evidence for score:**
- PS Integration provides 5 Phase 2 conditions — STRONG
- Each AGREE section ends with "Implication" paragraph — STRONG directional, MODERATE specificity
- Phase 2 design constraints are scattered and not consolidated (SM-003, PM-001) — MAJOR GAP
- THEME-2 effectiveness hierarchy is actionable as a design tool — STRONG
- Warning-based meta-prompts (+25.14%) identified as "most actionable" — SPECIFIC
- The declarative vs. imperative distinction in THEME-1 is identified as testable — ACTIONABLE
- "Next agent hint" in PS Integration is specific — STRONG

**Justification for 0.84:** The synthesis has good actionability for its Phase 2 design purpose, but Phase 2 design constraints are scattered rather than consolidated. Score 0.84 reflects "highly actionable content with organizational fragmentation reducing immediate usability."

---

#### Dimension 6: Traceability (weight: 0.10)

**Score: 0.86**

**Evidence for score:**
- All synthesis claims attributed to (Survey, Source ID) notation — STRONG
- Deduplication decisions documented with specific source pairs — STRONG
- Source catalog provides full bibliographic entries for each source — STRONG
- Agreement-to-source traceability: each AGREE entry cites the specific survey section and quote — STRONG
- Gap-to-source traceability: each GAP entry identifies the source and explains absence from others — STRONG
- PS Integration "5 conditions" recommendation not explicitly traced to specific AGREE/GAP entries (CV-003) — MODERATE GAP
- DSPy paper (C-13) venue not identified — MINOR GAP

**Justification for 0.86:** Traceability is the synthesis's strongest dimension. The (Survey, Source ID) notation is consistently applied throughout. The PS Integration 5-conditions recommendation has the primary traceability gap. Score 0.86 reflects "strong traceability with minor gaps in derived recommendations."

---

### Weighted Composite Calculation

```
Composite = (Completeness × 0.20) + (Internal Consistency × 0.20) + (Methodological Rigor × 0.20)
          + (Evidence Quality × 0.15) + (Actionability × 0.15) + (Traceability × 0.10)

= (0.82 × 0.20) + (0.78 × 0.20) + (0.87 × 0.20) + (0.81 × 0.15) + (0.84 × 0.15) + (0.86 × 0.10)

= 0.164 + 0.156 + 0.174 + 0.1215 + 0.126 + 0.086

= 0.8275

≈ 0.83
```

### Verdict

**Score: 0.83**
**Verdict: REVISE**
**C4 Threshold: 0.95 — FAILED**
**General Threshold (H-13): 0.92 — FAILED**

**Special Conditions Check:**
- Any dimension <= 0.50 (Critical)? No — minimum dimension score is 0.78 (Internal Consistency)
- Prior strategy reports contain unresolved Critical findings? Yes — DA-001, RT-001, IN-001 are Critical findings requiring resolution

**Verdict override per special conditions:** REVISE (Critical findings from DA, RT, IN strategies remain unresolved).

### Dimension Scores Summary

| Dimension | Weight | Score | Weighted | Notes |
|-----------|--------|-------|----------|-------|
| Completeness | 0.20 | 0.82 | 0.164 | Agreement count error; Phase 2 design scattered |
| Internal Consistency | 0.20 | 0.78 | 0.156 | CRITICAL: 7 vs 5 STRONG agreements; directional overstatement in L0 |
| Methodological Rigor | 0.20 | 0.87 | 0.174 | Strong methodology; publication bias gap |
| Evidence Quality | 0.15 | 0.81 | 0.1215 | L0 overcites Tier 3; DSPy venue gap |
| Actionability | 0.15 | 0.84 | 0.126 | Scattered Phase 2 design constraints |
| Traceability | 0.10 | 0.86 | 0.086 | Strong; PS Integration 5-conditions traceability gap |
| **Composite** | **1.00** | **0.83** | **0.83** | Below H-13 threshold (0.92) and C4 threshold (0.95) |

### Improvement Recommendations (Priority Order)

| Priority | Dimension | Gap | Target Score | Recommendation |
|----------|-----------|-----|-------------|----------------|
| 1 | Internal Consistency | STRONG agreement count (7 stated, 5 documented) | 0.90+ | Correct L0 Key Numbers to 5 STRONG / 4 MODERATE (9 total) |
| 2 | Internal Consistency | L0 directional overstatement | 0.90+ | Revise "evidence more consistently suggests the opposite" to null-finding language |
| 3 | Completeness | Phase 2 design scattered | 0.87+ | Add consolidated "Phase 2 Experimental Design Requirements" section |
| 4 | Evidence Quality | L0 Tier 3 overciting | 0.86+ | Remove specific percentages (26%→59%) from L0; cite directionally only |
| 5 | Completeness | Scope exclusion not documented | 0.86+ | Add "Known Scope Exclusions" section |
| 6 | Evidence Quality | DSPy paper venue unidentified | 0.85+ | Identify venue for arXiv:2312.13382 |
| 7 | Traceability | PS Integration 5-conditions derivation | 0.90+ | Add explicit derivation of each Phase 2 condition from synthesis findings |

### Leniency Bias Verification

- Each dimension scored independently: YES
- Evidence documented for each score: YES
- Uncertain scores resolved downward: YES (0.78 Internal Consistency chosen over 0.80 due to the factual error severity)
- High-scoring dimensions (> 0.90): Methodological Rigor (0.87), Traceability (0.86) — both below 0.90, no high-score verification needed
- Low-scoring dimension evidence:
  1. Internal Consistency (0.78): L0 states 7 STRONG agreements; body has 5. L0 directional claim overstates Tier 3 evidence.
  2. Completeness (0.82): Phase 2 design scattered across 9 sections. Known scope exclusions absent.
  3. Evidence Quality (0.81): A-6 percentages in L0 without tier caveat. DSPy peer-review venue unstated.
- Weighted composite math verified: 0.164 + 0.156 + 0.174 + 0.1215 + 0.126 + 0.086 = 0.8275 ≈ 0.83 ✓
- Verdict matches score range: REVISE (0.83 is in 0.70-0.84 range) ✓
- Improvement recommendations are specific and actionable: YES

---

## Consolidated Findings Index

| ID | Strategy | Severity | Finding (one-line) | Section |
|----|----------|----------|--------------------|---------|
| SR-001 | S-010 | Major | Source count arithmetic not independently verifiable from deduplication table | Source Count Verification |
| SR-002 | S-010 | Major | Latitude 30%/25% figures not flagged in body (only in audit section) | L1: Unsourced Claim Audit |
| SR-003 | S-010 | Major | No per-agreement confidence scores; document-level 0.85 applied uniformly | L1: Agreements, Gaps |
| SR-004 | S-010 | Minor | AGREE-6/AGREE-7 MODERATE status not visually distinct from STRONG in document flow | L1: Agreements |
| SR-005 | S-010 | Minor | Tier 3 count listed as 12 in table, 13 in note | L1: Evidence Tier Analysis |
| SR-006 | S-010 | Minor | PS Integration lacks handoff schema fields (from_agent, to_agent, key_findings format) | PS Integration |
| SR-007 | S-010 | Minor | CONFLICT-4 "UNRESOLVED" label inconsistent with DSPy practical resolution noted in body | L1: Conflicts |
| SM-001 | S-003 | Major | Effectiveness hierarchy (THEME-2) lacks access-level column distinguishing prompt-only from infra-required | L2: THEME-2 |
| SM-002 | S-003 | Major | AGREE-4 leads with rejected paper (A-16) for quantitative claims instead of Tier 1 sources | L1: AGREE-4 |
| SM-003 | S-003 | Major | Phase 2 implications scattered across 9 entries; no consolidated design requirements section | L1: Agreements, Gaps, L2: Themes |
| SM-004 | S-003 | Minor | THEME-1 hypothesis ("declarative negation works through self-model") not specified as testable | L2: THEME-1 |
| SM-005 | S-003 | Minor | Best Case Scenario for synthesis argument not articulated | General |
| SM-006 | S-003 | Minor | CONFLICT-2 resolution explanations not ranked by testability | L1: CONFLICT-2 |
| DA-001 | S-002 | Critical | "Evidence more consistently suggests the opposite" conflates evidence absence with directional evidence | L0: Executive Summary |
| DA-002 | S-002 | Major | Key Numbers states 7 STRONG agreements; body documents 5 | L0: Key Numbers |
| DA-003 | S-002 | Major | Hypothesis declared untested but L0 framing implies refutation | L0: Executive Summary, AGREE-1 |
| DA-004 | S-002 | Major | Revised hypothesis is hypothesis substitution, not refinement | L0: Executive Summary |
| DA-005 | S-002 | Major | Tier 4 vendor consensus elevated as "strongest evidence" above Tier 1 experimental data | L1: Evidence Tier Analysis |
| DA-006 | S-002 | Minor | THEME-3 speculation about GPT-5.2 following flawed instructions "too literally" is unsupported | L2: THEME-3 |
| DA-007 | S-002 | Minor | CONFLICT-2 explanation (1) declared "most parsimonious" without elimination of alternatives | L1: CONFLICT-2 |
| PM-001 | S-004 | Major | Phase 2 analyst may miss 5-condition design because it is buried in PS Integration | PS Integration |
| PM-002 | S-004 | Major | Agreement count error in L0 will propagate to external citations | L0: Key Numbers |
| PM-003 | S-004 | Major | Tier 4 unverified quantitative figures (GAP-5) may be cited as validated findings by practitioners | L1: Gaps |
| PM-004 | S-004 | Major | L0 verdict may be used to argue against Phase 2 funding (premature refutation framing) | L0: Executive Summary |
| PM-005 | S-004 | Minor | Deduplication log not independently reproducible | Source Count Verification |
| PM-006 | S-004 | Minor | THEME-1 may be criticized as repackaging of CONFLICT-2 | L2: THEME-1 |
| RT-001 | S-001 | Critical | L0 verdict phrasing implies hypothesis tested and found false, not just untested | L0: Executive Summary |
| RT-002 | S-001 | Major | AGREE-6 hallucination claim rests solely on one Tier 3 paper (A-6); highly vulnerable | L1: AGREE-6 |
| RT-003 | S-001 | Major | Publication bias potential: negative results may be overrepresented in academic search | L1: Agreements |
| RT-004 | S-001 | Major | Industry consensus traced through circular citation chain (blogs citing each other → A-9) | L1: AGREE-4 |
| RT-005 | S-001 | Minor | "Negative prompting" scope conflation across 4 distinct phenomena | L2: THEME-2 |
| RT-006 | S-001 | Minor | THEME-1 mechanistic claim ("self-model") requires interpretability evidence not cited | L2: THEME-1 |
| RT-007 | S-001 | Minor | No systematic assessment of pre-2024 vs. post-2024 evidence proportion | L2: THEME-3 |
| CC-001 | S-007 | Major | P-001 partial violation: directional language overstates Tier 3 evidence strength | L0: Executive Summary |
| CC-002 | S-007 | Major | P-022 partial violation: L0 agreement count misrepresents body content | L0: Key Numbers |
| CC-003 | S-007 | Minor | H-23 navigation table — SATISFIED (no finding) | Document Sections |
| CC-004 | S-007 | Minor | P-011 partial: THEME-1 mechanistic claim unsupported by interpretability evidence | L2: THEME-1 |
| CV-001 | S-011 | Major | Bsharat et al. (55% figure) cited via PromptHub secondary; primary paper absent from catalog | L1: AGREE-4 |
| CV-002 | S-011 | Major | DSPy Assertions peer-reviewed paper venue not identified (C-13 "accepted at venue") | GAP-6 |
| CV-003 | S-011 | Major | Phase 2 "5 conditions" recommendation not explicitly derived from documented synthesis findings | PS Integration |
| CV-004 | S-011 | Minor | A-16 rejection status not prominent in AGREE-4 supporting evidence | L1: AGREE-4 |
| CV-005 | S-011 | Minor | A-21 "3 runs" claim in CONFLICT-4 not verifiable from synthesis alone | L1: CONFLICT-4 |
| FM-001 | S-012 | Major | Agreement count error propagation risk — RPN 448 (highest) | L0: Key Numbers |
| FM-002 | S-012 | Major | Null finding misread as directional finding — RPN 378 (second highest) | L0: Executive Summary |
| FM-003 | S-012 | Major | Unverified Tier 4 quantitative figures propagate as validated — RPN 210 | L1: Gaps |
| FM-004 | S-012 | Minor | A-6 hallucination percentages generalized beyond task scope — RPN 200 | L1: AGREE-6 |
| FM-005 | S-012 | Minor | 5-condition Phase 2 design not implemented by analyst — RPN 196 | PS Integration |
| FM-006 | S-012 | Minor | 74 source count not independently reproducible — RPN 144 | Source Count Verification |
| IN-001 | S-013 | Critical | Core conclusion fails domain-specific inversion: production/expert deployment evidence excluded | L1: Agreements (general) |
| IN-002 | S-013 | Major | A-23 warning-based meta-prompt recommendation rests on single study; inversion reveals fragility | GAP-2 |
| IN-003 | S-013 | Major | Vendor consensus inversion (vendor bias) not addressed in synthesis | L1: Evidence Tier Analysis |
| IN-004 | S-013 | Minor | AGREE-4 expert-user inversion not addressed | L1: AGREE-4 |
| IN-005 | S-013 | Minor | Structural enforcement evidence may not generalize to linguistic framing claims | L2: THEME-5 |
| LJ-001 | S-014 | Major | Completeness: 0.82 — agreement count error and scattered Phase 2 design | L0, PS Integration |
| LJ-002 | S-014 | Major | Internal Consistency: 0.78 — factual count error and directional overstatement | L0: Key Numbers, L0: Executive Summary |
| LJ-003 | S-014 | Minor | Methodological Rigor: 0.87 — strong, minor publication bias gap | L1: Agreements |
| LJ-004 | S-014 | Major | Evidence Quality: 0.81 — Tier 3 in L0, DSPy venue gap, secondary citation | L0, GAP-6, AGREE-4 |
| LJ-005 | S-014 | Minor | Actionability: 0.84 — scattered Phase 2 design | PS Integration |
| LJ-006 | S-014 | Minor | Traceability: 0.86 — strong, PS Integration 5-conditions gap | PS Integration |

---

## Revision Priorities

Ordered by impact on quality score and risk severity (RPN):

### Priority 1 — Must Fix Before Any External Use (Critical/High-RPN)

| # | Finding IDs | Action | Estimated Score Impact |
|---|-------------|--------|----------------------|
| 1 | DA-002, CC-002, FM-001, LJ-002 | Correct L0 Key Numbers: 5 STRONG / 4 MODERATE = 9 total agreements (not 7/9=16) | +0.04 Internal Consistency |
| 2 | DA-001, RT-001, CC-001, FM-002, LJ-002 | Revise L0 verdict language: separate null finding from directional claim; remove "evidence more consistently suggests the opposite" | +0.04 Internal Consistency, +0.02 Evidence Quality |
| 3 | IN-001, RT-003 | Add "Known Scope Exclusions" section: production deployments, domain-specific expert applications, grey literature | +0.02 Completeness |

### Priority 2 — Required Before Phase 2 Handoff (Major findings)

| # | Finding IDs | Action | Estimated Score Impact |
|---|-------------|--------|----------------------|
| 4 | SM-003, PM-001, CV-003, LJ-005 | Add "Phase 2 Experimental Design Requirements" section consolidating all implications with condition derivations | +0.04 Actionability, +0.02 Traceability |
| 5 | RT-002, LJ-004 | Remove A-6 specific percentages (26%→59%) from L0; use directional language only | +0.02 Evidence Quality |
| 6 | SR-001, FM-006 | Add explicit arithmetic trace for 74-source count (Group A + Group I net-of-overlaps + Group C net-of-overlaps) | +0.02 Completeness, +0.01 Traceability |
| 7 | CV-001 | Add Bsharat et al. (2023) primary paper to source catalog; note I-13 as secondary citation | +0.01 Traceability |
| 8 | CV-002 | Identify DSPy Assertions (arXiv:2312.13382) publication venue; update GAP-6 tier assessment | +0.01 Evidence Quality |
| 9 | SM-002 | Restructure AGREE-4: lead with A-20 (Geng, AAAI 2026) and A-19 (Tripathi); relegate A-16 to corroborating caveat | +0.01 Evidence Quality |
| 10 | DA-004 | Label revised hypothesis explicitly as "Alternative Hypothesis" distinct from PROJ-014 working hypothesis | +0.01 Internal Consistency |

### Priority 3 — Improvements for Iteration 2+ (Minor findings)

| # | Finding IDs | Action |
|---|-------------|--------|
| 11 | SM-001 | Add access-level column to THEME-2 effectiveness hierarchy (prompt-only / infra-required / model-access-required) |
| 12 | SM-004 | Add testable prediction to THEME-1 declarative vs. imperative distinction |
| 13 | DA-005 | Reframe vendor consensus as "broadest operational consensus" not "strongest evidence" |
| 14 | IN-002 | Add replication caveat to A-23 (warning-based meta-prompt) recommendation |
| 15 | SR-003 | Add per-agreement confidence qualifiers (High/Medium/Low) to AGREE sections |

---

## Execution Statistics

| Strategy | Critical | Major | Minor | Total Findings |
|----------|----------|-------|-------|----------------|
| S-010 Self-Refine | 0 | 3 | 4 | 7 |
| S-003 Steelman | 0 | 3 | 3 | 6 |
| S-002 Devil's Advocate | 1 | 4 | 2 | 7 |
| S-004 Pre-Mortem | 0 | 4 | 2 | 6 |
| S-001 Red Team | 1 | 3 | 3 | 7 |
| S-007 Constitutional AI | 0 | 2 | 2 | 4 |
| S-011 Chain-of-Verification | 0 | 3 | 2 | 5 |
| S-012 FMEA | 0 | 3 | 3 | 6 (see FMEA table) |
| S-013 Inversion | 1 | 2 | 2 | 5 |
| S-014 LLM-as-Judge | 0 | 3 | 3 | 6 |
| **TOTAL** | **3** | **30** | **26** | **59** |

**Protocol Steps Completed:** All 10 strategies executed. S-014 Step 7 (persist score report) fulfilled by this document.

**S-014 Final Score:** 0.83 / 1.00
**Verdict:** REVISE (below H-13 threshold of 0.92; below C4 threshold of 0.95)
**Revision Required:** YES — minimum Priority 1 actions before external use; full Priority 2 before Phase 2 handoff

---

*Execution Report Version: 1.0 (Iteration 1)*
*Agent: adv-executor*
*Strategy Templates: S-010 v1.0.0, S-003 v1.0.0, S-002 v1.0.0, S-004 v1.0.0, S-001 v1.0.0, S-007 v1.0.0, S-011 v1.0.0, S-012 v1.0.0, S-013 v1.0.0, S-014 v1.0.0*
*Template Path: `.context/templates/adversarial/`*
*H-15 Self-Review: Applied — findings cross-checked against deliverable; severity classifications verified; summary table matches detailed findings*
*P-003 Compliance: No subagents spawned. Read, Glob, Grep, Write tools only.*
*P-022 Compliance: Score of 0.83 reflects genuine assessment; no minimization of findings*
